Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors.

Precious BarnesF A YeboahJinling ZhuRoland Osei SaaheneChristian ObirikorangMichael Buenor AdinorteyBenjamin AmoaniFoster KyeiPatrick AkakpoYaw Asante Awuku

Published in: Journal of cancer epidemiology (2020)

EGFR can serve as a prognostic marker in monitoring patients with HNT as well as a molecular therapeutic target.

Keyphrases

epidermal growth factor receptor
tyrosine kinase
advanced non small cell lung cancer
small cell lung cancer
single molecule